Peroxisome proliferator-activated receptor-gamma might be a useful intracellular target for the treatment of psoriasis; further study is needed to assess the clinical value of ligands for PPARgamma, including troglitazone.
No takes yet. Share an insight, caveat, or question.
Ellis et al. (2000) studied this question.